- Home
- VGI vs MAIA Comparison
VGI vs MAIA Comparison
Compare VGI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGI
- MAIA
- Stock Information
- Founded
- VGI 2012
- MAIA 2018
- Country
- VGI United States
- MAIA United States
- Employees
- VGI N/A
- MAIA N/A
- Industry
- VGI Investment Managers
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- VGI Finance
- MAIA Health Care
- Exchange
- VGI Nasdaq
- MAIA Nasdaq
- Market Cap
- VGI N/A
- MAIA 46.7M
- IPO Year
- VGI N/A
- MAIA 2022
- Fundamental
- Price
- VGI $7.89
- MAIA $2.06
- Analyst Decision
- VGI
- MAIA
- Analyst Count
- VGI 0
- MAIA 0
- Target Price
- VGI N/A
- MAIA N/A
- AVG Volume (30 Days)
- VGI 46.0K
- MAIA 425.0K
- Earning Date
- VGI 01-01-0001
- MAIA 08-08-2025
- Dividend Yield
- VGI 12.66%
- MAIA N/A
- EPS Growth
- VGI N/A
- MAIA N/A
- EPS
- VGI N/A
- MAIA N/A
- Revenue
- VGI N/A
- MAIA N/A
- Revenue This Year
- VGI N/A
- MAIA N/A
- Revenue Next Year
- VGI N/A
- MAIA N/A
- P/E Ratio
- VGI N/A
- MAIA N/A
- Revenue Growth
- VGI N/A
- MAIA N/A
- 52 Week Low
- VGI $6.68
- MAIA $1.40
- 52 Week High
- VGI $7.99
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- VGI 63.10
- MAIA 64.26
- Support Level
- VGI $7.82
- MAIA $1.80
- Resistance Level
- VGI $7.97
- MAIA $2.03
- Average True Range (ATR)
- VGI 0.07
- MAIA 0.13
- MACD
- VGI 0.01
- MAIA 0.03
- Stochastic Oscillator
- VGI 82.98
- MAIA 93.88
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.